Global Information
회사소개 | 문의 | 위시리스트

세계의 종양 절제 시장 : 시장 분석, 기업 개요, 시장 규모, 시장 점유율, 성장률, 동향 및 향후 예측

Global Tumor Ablation Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

리서치사 Data Bridge Market Research Private Limited
발행일 2017년 09월 상품 코드 587832
페이지 정보 영문 350 Pages
가격
US $ 4,200 ₩ 5,143,000 Web Access (Single User License) - Read Only help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste, 다운로드 및 인쇄가 불가합니다.
US $ 5,400 ₩ 6,613,000 Web Access (Enterprise License) - Printable/Downloadable help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste, 다운로드 및 인쇄가 가능합니다. 인쇄 횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 종양 절제 시장 : 시장 분석, 기업 개요, 시장 규모, 시장 점유율, 성장률, 동향 및 향후 예측 Global Tumor Ablation Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
발행일 : 2017년 09월 페이지 정보 : 영문 350 Pages

세계의 종양 절제(Tumor Ablation) 시장에 대해 조사했으며, 시장 개요, 종류·종양·최종사용자·지역별 시장 동향, 시장 규모와 예측, 시장 성장 촉진요인 및 시장 기회·과제 분석, 시장 점유율, 경쟁 구도, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 시장 상황

제4장 시장 개요

  • 시장 개요
  • 주요 조사 결과
  • 시장 성장 촉진요인, 시장 기회, 과제
  • 주요 조사 결과
  • 시장 동향과 향후 기대되는 신기술

제5장 세계의 종양 절제 시장 : 종류별

  • 시장 개요
  • 종양 절제 시스템
    • 고주파 절제
    • 마이크로파 절제
    • 고강도집속초음파(HIFU) 절제
    • 레이저 절제
    • 냉동 절제
  • 영상 유도 기기
  • 부속품

제6장 세계의 종양 절제 시장 : 종양별

  • 시장 개요
  • 간암
  • 뇌종양
  • 폐암
  • 골육종
  • 신장암
  • 췌장암
  • 유방암

제7장 세계의 종양 절제 시장 : 최종사용자별

  • 시장 개요
  • 병원
  • 진료소
  • 기타

제8장 세계의 종양 절제 시장 : 지역별

  • 개요
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 기타 지역
  • 주요 국가 분석

제9장 경쟁 구도

  • 전체 : 기업의 시장 점유율
  • 북미 : 기업의 시장 점유율
  • 유럽 : 기업의 시장 점유율
  • 아시아태평양 : 기업의 시장 점유율
  • 인수합병
  • 신제품 개발과 승인
  • 사업 확장
  • 규제 상황 변화
  • 파트너십 및 기타 전략 동향

제10장 기업 개요

  • MEDTRONIC
  • GALIL MEDICAL, INC.
  • PERSEON CORPORATION
  • NEUWAVE MEDICAL, INC.
  • KONINKLIJKE PHILIPS N.V.
  • INTIO INC.
  • MERMAID MEDICAL A/S
  • SONACARE MEDICAL, LLC
  • DFINE, INC.
  • MISONIX, INC.
  • BVM MEDICAL LIMITED
  • ANGIODYNAMICS, INC.
  • COMSOL INC.
  • BOSTON SCIENTIFIC CORPORATION
  • EDAP TMS S.A.
  • HEALTHTRONICS, INC.

제11장 부록

제12장 Data Bridge Market Research 소개

KSM 17.12.20

Title:
Global Tumor Ablation market
By Type (Tumor Ablation Systems {Radio Frequency Ablation System, Microwave Ablation System, Cryoablation, High Intensity Focused Ultrasound , Laser Ablation System}, Image Guidance Products, Accessories), By Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer, Others), By Mode of Treatment (Surgical, Laparoscopic, Percutaneous), By End User (Hospitals, Oncology Clinics, Others), By Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2024.

The Global Tumor Ablation Market is accounted to reach USD 3,495.0 million by 2024 from USD 1,669.7 million in 2016,it is growing at a CAGR of 9.8% in the forecast period 2017 to 2024.

The major factors contributing to the growth of the market includes incidences of cancer patients, increase in the number of hospitals, ablation and surgical centers, technological advancement in ablation devices.

The key market players for Global Tumor Ablation Market are listed below:

  • Boston Scientific Corporation
  • Abbott
  • Galil Medical Inc.,
  • Perseon Corporation,
  • NeuWave Medical, Inc.,
  • Koninklijke Philips N.V.,
  • INTIO Inc.,
  • Mermaid Medical A/S,
  • SonaCare Medical,
  • LLC, DFINE, Inc.,
  • Misonix,
  • BVM Medical Limited,
  • AngioDynamics,
  • COMSOL Inc,
  • EDAP TMS,
  • HealthTronics, Inc.

The market is further segmented into:

  • Type
  • Application
  • End User
  • Geography

The global tumor ablation market is segmented on the basis of type, cancer type, mode of treatment, end user, and geography. On the basis of type, the market is segmented into three major segments which include tumor ablation systems, image guidance products, and accessories.

In 2017, the Tumor Ablation Systems market segment is expected to dominate the market with 69.2%. Tumor Ablation Systems is further sub segmented into radio frequency ablation system (RFA), microwave ablation system, cryoablation, high intensity focused ultrasound and laser ablation system. In 2017, radio frequency ablation system (RFA) market segment is expected to dominate the market with 53.8%.

Based on cancer type, the market is segmented into eight major segments which include liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer and others, The lung cancer market is expected to grow at the highest CAGR 10.7% in the forecast period of 2017 to 2024.

Based on mode of treatment, the global tumor ablation market is segmented into surgical, laproscopic and percutaneous. The Surgical is projected to witness higher growth during the forecast period., The laparoscopic market is expected to grow at the highest CAGR 10.8% in the forecast period of 2017 to 2024.

Based on end users, the market is segmented into hospital, oncology clinics, and others. In 2017, the hospital market segment is expected to dominate the market. with a share of 68.3%.

Based on geography, the Global Tumor Ablation market is segmented into geographical regions, such as,

  • North America,
  • Europe,
  • Asia-Pacific,
  • South America
  • Middle East & Africa

Covered in this report:

The report covers the present scenario and the growth prospects of the Global Tumor Ablation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

1. INTRODUCTION

  • 1.1. OVERVIEW OF THE TUMOUR ABLATION MARKET
  • 1.2. MARKET SEGMENTATION & COVERAGE

2. RESEARCH METHODOLOGY

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE TUMOUR ABLATION MARKET SIZE
    • 2.2.1. MARKET CRACKDOWN APPROACH
    • 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
    • 2.2.3. DATA TRIANGULATION
    • 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
    • 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
    • 2.2.6. PORTER'S FIVE FORCES MATRIX
    • 2.2.7. PEST ANALYSIS
    • 2.2.8. EPIDEMIOLOGY FORECASTING MODELS
  • 2.3. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. MARKET OVERVIEW

  • 4.1. OVERVIEW
  • 4.2. TUMOUR ABLATION MARKET: KEY PRIMARY INSIGHTS
  • 4.3. DRIVERS, OPPORTUNITIES AND THREAT ANALYSIS MATRIX
  • 4.4. KEY MARKET FINDINGS
  • 4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. TUMOUR ABLATION MARKET, BY TYPE

  • 5.1. OVERVIEW
  • 5.2. TUMOUR ABLATION SYSTEMS
    • 5.2.1. RADIO FREQUENCY ABLATION SYSTEM (RFA)
    • 5.2.2. MICROWAVE ABLATION SYSTEM
    • 5.2.3. HIGH FREQUENCY FOCUSED ULTRASOUND ABLATION SYSTEM (HIFU)
    • 5.2.4. LASER ABLATION SYSTEM
    • 5.2.5. CRYOABLATION
  • 5.3. IMAGE GUIDANCE PRODUCTS
  • 5.4. ACCESSORIES

6. TUMOUR ABLATION MARKET, BY CANCER TYPE

  • 6.1. OVERVIEW
  • 6.2. LIVER CANCER
  • 6.3. BRAIN CANCER
  • 6.4. LUNG CANCER
  • 6.5. BONE CANCER
  • 6.6. KIDNEY CANCER
  • 6.7. PANCREATIC CANCER
  • 6.8. BREAST CANCER
  • 6.9. OTHERS

7. TUMOR ABLATION MARKET, BY END-USER

  • 7.1. OVERVIEW
  • 7.2. HOSPITALS
  • 7.3. ONCOLOGY CLINICS
  • 7.4. OTHERS

8. TUMOUR ABLATION MARKET, BY GEOGRAPHY

  • 8.1. COUNTRYWISE TUMOUR ABLATION MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
    • 8.1.1. NORTH AMERICA
      • 8.1.1.1. U.S.
      • 8.1.1.2. CANADA
      • 8.1.1.3. MEXICO
    • 8.1.2. EUROPE
      • 8.1.2.1. GERMANY
      • 8.1.2.2. FRANCE
      • 8.1.2.3. U.K.
      • 8.1.2.4. ITALY
      • 8.1.2.5. SPAIN
      • 8.1.2.6. RUSSIA
      • 8.1.2.7. TURKEY
      • 8.1.2.8. BELGIUM
      • 8.1.2.9. NETHERLANDS
      • 8.1.2.10. SWITZERLAND
      • 8.1.2.11. REST OF EUROPE
    • 8.1.3. ASIA-PACIFIC (APAC)
      • 8.1.3.1. JAPAN
      • 8.1.3.2. CHINA
      • 8.1.3.3. SOUTH KOREA
      • 8.1.3.4. INDIA
      • 8.1.3.5. AUSTRALIA
      • 8.1.3.6. SINGAPORE
      • 8.1.3.7. THAILAND
      • 8.1.3.8. MALAYSIA
      • 8.1.3.9. REST OF APAC
    • 8.1.4. LATIN AMERICA
      • 8.1.4.1. BRAZIL
      • 8.1.4.2. REST OF LATIN AMERICA
    • 8.1.5. REST OF THE WORLD
  • 8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

9. TUMOUR ABLATION MARKET: COMPETITIVE LANDSCAPE

  • 9.1. GLOBAL TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
  • 9.2. NORTH AMERICA TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
  • 9.3. EUROPE TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
  • 9.4. APAC TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
  • 9.5. MERGERS & ACQUISITIONS
  • 9.6. NEW PRODUCT DEVELOPMENT & APPROVALS
  • 9.7. EXPANSIONS
  • 9.8. REGULATORY CHANGES
  • 9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

10. TUMOUR ABLATION MARKET, COMPANY PROFILES

  • 10.1. MEDTRONIC
    • 10.1.1 OVERVIEW
    • 10.1.2 SWOT ANALYSIS
    • 10.1.3 PRODUCT PORTFOLIO
    • 10.1.4 REVENUE ANALYSIS
    • 10.1.5 ANALYSTS VIEW
  • 10.2. GALIL MEDICAL, INC.
    • 10.2.1 OVERVIEW
    • 10.2.2 SWOT ANALYSIS
    • 10.2.3 PRODUCT PORTFOLIO
    • 10.2.4 REVENUE ANALYSIS
    • 10.2.5 ANALYSTS VIEW
  • 10.3 PERSEON CORPORATION
    • 10.3.1 OVERVIEW
    • 10.3.2 SWOT ANALYSIS
    • 10.3.3 PRODUCT PORTFOLIO
    • 10.3.4 REVENUE ANALYSIS
    • 10.3.5 ANALYST VIEW
  • 10.4 NEUWAVE MEDICAL, INC.
    • 10.4.1 OVERVIEW
    • 10.4.2 SWOT ANALYSIS
    • 10.4.3 PRODUCT PORTFOLIO
    • 10.4.4 REVENUE ANALYSIS
    • 10.4.5 ANALYSTS VIEW
  • 10.5. KONINKLIJKE PHILIPS N.V.
    • 10.5.1 OVERVIEW
    • 10.5.2 SWOT ANALYSIS
    • 10.5.3 PRODUCT PORTFOLIO
    • 10.5.4 REVENUE ANALYSIS
    • 10.5.5 ANALYSTS VIEW
  • 10.6. INTIO INC.
    • 10.6.1 OVERVIEW
    • 10.6.2 SWOT ANALYSIS
    • 10.6.3 PRODUCT PORTFOLIO
    • 10.6.4 REVENUE ANALYSIS
    • 10.6.5 ANALYSTS VIEW
  • 10.7. MERMAID MEDICAL A/S
    • 10.7.1 OVERVIEW
    • 10.7.2 SWOT ANALYSIS
    • 10.7.3 PRODUCT PORTFOLIO
    • 10.7.4 REVENUE ANALYSIS
    • 10.7.5 ANALYSTS VIEW
  • 10.8. SONACARE MEDICAL, LLC
    • 10.8.1 OVERVIEW
    • 10.8.2 SWOT ANALYSIS
    • 10.8.3 PRODUCT PORTFOLIO
    • 10.8.4 REVENUE ANALYSIS
    • 10.8.5 ANALYSTS VIEW
  • 10.9. DFINE, INC.
    • 10.9.1. OVERVIEW
    • 10.9.2. SWOT ANALYSIS
    • 10.9.3. PRODUCT PORTFOLIO
    • 10.9.4. REVENUE ANALYSIS
    • 10.9.5. ANALYSTS VIEW
  • 10.10. MISONIX, INC.
    • 10.10.1. OVERVIEW
    • 10.10.2. SWOT ANALYSIS
    • 10.10.3. PRODUCT PORTFOLIO
    • 10.10.4. REVENUE ANALYSIS
    • 10.10.5. ANALYSTS VIEW
  • 10.11. BVM MEDICAL LIMITED
    • 10.11.1. OVERVIEW
    • 10.11.2. SWOT ANALYSIS
    • 10.11.3. PRODUCT PORTFOLIO
    • 10.11.4. REVENUE ANALYSIS
    • 10.11.5. ANALYSTS VIEW
  • 10.12. ANGIODYNAMICS, INC.
    • 10.12.1. OVERVIEW
    • 10.12.2. SWOT ANALYSIS
    • 10.12.3. PRODUCT PORTFOLIO
    • 10.12.4. REVENUE ANALYSIS
    • 10.12.5. ANALYSTS VIEW
  • 10.13. COMSOL INC.
    • 10.13.1. OVERVIEW
    • 10.13.2. SWOT ANALYSIS
    • 10.13.3. PRODUCT PORTFOLIO
    • 10.13.4. REVENUE ANALYSIS
    • 10.13.5. ANALYSTS VIEW
  • 10.14. BOSTON SCIENTIFIC CORPORATION
    • 10.14.1. OVERVIEW
    • 10.14.2. SWOT ANALYSIS
    • 10.14.3. PRODUCT PORTFOLIO
    • 10.14.4. REVENUE ANALYSIS
    • 10.14.5. ANALYSTS VIEW
  • 10.15. EDAP TMS S.A.
    • 10.10.1. OVERVIEW
    • 10.10.2. SWOT ANALYSIS
    • 10.10.3. PRODUCT PORTFOLIO
    • 10.10.4. REVENUE ANALYSIS
    • 10.10.5. ANALYSTS VIEW
  • 10.16. HEALTHTRONICS, INC.
    • 10.11.1. OVERVIEW
    • 10.11.2. SWOT ANALYSIS
    • 10.11.3. PRODUCT PORTFOLIO
    • 10.11.4. REVENUE ANALYSIS
    • 10.11.5. ANALYSTS VIEW

11. APPENDIX

  • 11.1. RELATED REPORTS
  • 11.2. CUSTOMIZABLE OPTIONS
  • 11.3. SOURCE SHEET
  • 11.4. BIBLIOGRAPHY

12. ABOUT DATA BRIDGE MARKET RESEARCH

Back to Top
전화 문의
F A Q